Editorial Commentary: Top Five Stories of the Cellular Landscape and Therapies of Atherosclerosis: Current Knowledge and Future Perspectives

Overview

Journal Curr Med Sci

Specialty General Medicine

Date 2024 Jan 26

PMID 38277018

Authors

Miao Yu

Xiang Cheng

Affiliations

Soon will be listed here.

References

Roth G, Mensah G, Johnson C, Addolorato G, Ammirati E, Baddour L . Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020; 76(25):2982-3021. PMC: 7755038. DOI: 10.1016/j.jacc.2020.11.010. View

Liu C, Li Z, Li B, Liu W, Zhang S, Qiu K . Relationship between ferroptosis and mitophagy in cardiac ischemia reperfusion injury: a mini-review. PeerJ. 2023; 11:e14952. PMC: 10019339. DOI: 10.7717/peerj.14952. View

He X, Fan X, Bai B, Lu N, Zhang S, Zhang L . Pyroptosis is a critical immune-inflammatory response involved in atherosclerosis. Pharmacol Res. 2021; 165:105447. DOI: 10.1016/j.phrs.2021.105447. View

Tao X, Wan X, Wu D, Song E, Song Y . A tandem activation of NLRP3 inflammasome induced by copper oxide nanoparticles and dissolved copper ion in J774A.1 macrophage. J Hazard Mater. 2021; 411:125134. DOI: 10.1016/j.jhazmat.2021.125134. View

Ridker P . From CANTOS to CIRT to COLCOT to Clinic: Will All Atherosclerosis Patients Soon Be Treated With Combination Lipid-Lowering and Inflammation-Inhibiting Agents?. Circulation. 2020; 141(10):787-789. DOI: 10.1161/CIRCULATIONAHA.119.045256. View

Yang M, Lv H, Liu Q, Zhang L, Zhang R, Huang X . Colchicine Alleviates Cholesterol Crystal-Induced Endothelial Cell Pyroptosis through Activating AMPK/SIRT1 Pathway. Oxid Med Cell Longev. 2020; 2020:9173530. PMC: 7378601. DOI: 10.1155/2020/9173530. View

Zhang F, He Q, Qin C, Little P, Weng J, Xu S . Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review. Acta Pharmacol Sin. 2022; 43(9):2173-2190. PMC: 8767044. DOI: 10.1038/s41401-021-00835-w. View

Hansson G, Libby P, Tabas I . Inflammation and plaque vulnerability. J Intern Med. 2015; 278(5):483-93. PMC: 5082111. DOI: 10.1111/joim.12406. View

Singla B, Lin H, Ahn W, Xu J, Ma Q, Sghayyer M . Loss of myeloid cell-specific SIRPα, but not CD47, attenuates inflammation and suppresses atherosclerosis. Cardiovasc Res. 2021; 118(15):3097-3111. PMC: 9732525. DOI: 10.1093/cvr/cvab369. View

10.

Azcutia V, Routledge M, Williams M, Newton G, Frazier W, Manica A . CD47 plays a critical role in T-cell recruitment by regulation of LFA-1 and VLA-4 integrin adhesive functions. Mol Biol Cell. 2013; 24(21):3358-68. PMC: 3814154. DOI: 10.1091/mbc.E13-01-0063. View

11.

Kojima Y, Volkmer J, McKenna K, Civelek M, Lusis A, Miller C . CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis. Nature. 2016; 536(7614):86-90. PMC: 4980260. DOI: 10.1038/nature18935. View

12.

Doring Y, Soehnlein O, Weber C . Neutrophil Extracellular Traps in Atherosclerosis and Atherothrombosis. Circ Res. 2017; 120(4):736-743. DOI: 10.1161/CIRCRESAHA.116.309692. View

13.

Vaidya K, Tucker B, Kurup R, Khandkar C, Pandzic E, Barraclough J . Colchicine Inhibits Neutrophil Extracellular Trap Formation in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention. J Am Heart Assoc. 2020; 10(1):e018993. PMC: 7955504. DOI: 10.1161/JAHA.120.018993. View

14.

Liberale L, Holy E, Akhmedov A, Bonetti N, Nietlispach F, Matter C . Interleukin-1β Mediates Arterial Thrombus Formation via NET-Associated Tissue Factor. J Clin Med. 2019; 8(12). PMC: 6947515. DOI: 10.3390/jcm8122072. View

15.

Gomez D, Owens G . Smooth muscle cell phenotypic switching in atherosclerosis. Cardiovasc Res. 2012; 95(2):156-64. PMC: 3388816. DOI: 10.1093/cvr/cvs115. View

16.

Orr A, Lee M, Lemmon J, Yurdagul Jr A, Gomez M, Schoppee Bortz P . Molecular mechanisms of collagen isotype-specific modulation of smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol. 2008; 29(2):225-31. PMC: 2692987. DOI: 10.1161/ATVBAHA.108.178749. View

17.

Bhaskar V, Yin J, Mirza A, Phan D, Vanegas S, Issafras H . Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice. Atherosclerosis. 2011; 216(2):313-20. DOI: 10.1016/j.atherosclerosis.2011.02.026. View

18.

Laera N, Malerba P, Vacanti G, Nardin S, Pagnesi M, Nardin M . Impact of Immunity on Coronary Artery Disease: An Updated Pathogenic Interplay and Potential Therapeutic Strategies. Life (Basel). 2023; 13(11). PMC: 10672143. DOI: 10.3390/life13112128. View

19.

Wang S, Hu S, Zhang Q, Xia A, Jiang Z, Chen X . Mesenchymal Stem Cells Stabilize Atherosclerotic Vulnerable Plaque by Anti-Inflammatory Properties. PLoS One. 2015; 10(8):e0136026. PMC: 4546153. DOI: 10.1371/journal.pone.0136026. View

20.

Frodermann V, van Duijn J, van Pel M, van Santbrink P, Bot I, Kuiper J . Mesenchymal Stem Cells Reduce Murine Atherosclerosis Development. Sci Rep. 2015; 5:15559. PMC: 4614841. DOI: 10.1038/srep15559. View